Target
Receptor-interacting serine/threonine-protein kinase 1
Ligand
BDBM50512997
Substrate
n/a
Meas. Tech.
ChEMBL_1851616 (CHEMBL4352240)
IC50
8.5±n/a nM
Citation
 Harris, PAFaucher, NGeorge, NEidam, PMKing, BWWhite, GVAnderson, NABandyopadhyay, DBeal, AMBeneton, VBerger, SBCampobasso, NCampos, SCapriotti, CACox, JADaugan, ADonche, FFouchet, MHFinger, JNGeddes, BGough, PJGrondin, PHoffman, BLHoffman, SJHutchinson, SEJeong, JUJigorel, ELamoureux, PLeister, LKLich, JDMahajan, MKMeslamani, JMosley, JENagilla, RNassau, PMNg, SLOuellette, MTPasikanti, KKPotvain, FReilly, MARivera, EJSautet, SSchaeffer, MCSehon, CASun, HThorpe, JHTotoritis, RDWard, PWellaway, NWisnoski, DDWoolven, JMBertin, JMarquis, RW Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase. J Med Chem 62:5096-5110 (2019) [PubMed]  Article
Target
Name:
Receptor-interacting serine/threonine-protein kinase 1
Synonyms:
Cell death protein RIP | RIP | RIP-1 | RIP1 | RIPK1 | RIPK1_HUMAN | Receptor-interacting protein 1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
75926.99
Organism:
Homo sapiens (Human)
Description:
Q13546
Residue:
671
Sequence:
MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN
  
Inhibitor
Name:
BDBM50512997
Synonyms:
CHEMBL4545939
Type:
Small organic molecule
Emp. Form.:
C18H19F2N5O2
Mol. Mass.:
375.3726
SMILES:
Cc1nnc(o1)N1CCC(CC1)C(=O)N1N=CC[C@H]1c1cc(F)cc(F)c1 |r,c:17|
Structure:
Search PDB for entries with ligand similarity: